Price T Rowe Associates Inc Agios Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,012,993 shares of AGIO stock, worth $84.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,012,993

Previous 1,624,612 23.91%

Holding current value

$84.6 Million

Previous $36.2 Million 62.68%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $8.28 Million - $13.5 Million	388,381 Added 23.91%	2,012,993 $58.9 Million
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $29,915 - $36,745	-1,498 Reduced 0.09%	1,624,612 $36.2 Million
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $8.11 Million - $9.38 Million	332,718 Added 25.72%	1,626,110 $40.2 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $634,879 - $866,797	29,695 Added 2.35%	1,293,392 $36.6 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $4.71 Million - $6.7 Million	-216,497 Reduced 14.63%	1,263,697 $29 Million

Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $92,318 - $117,285	3,721 Added 0.25%	1,480,194 $41.6 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $20.9 Million - $36.5 Million	-1,070,513 Reduced 42.03%	1,476,473 $41.8 Million
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $2.64 Million - $4.86 Million	-154,639 Reduced 5.72%	2,546,986 $56.5 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $4.72 Million - $6.16 Million	-177,089 Reduced 6.15%	2,701,625 $78.6 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $4.5 Million - $7.57 Million	-152,027 Reduced 5.02%	2,878,714 $94.6 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $1.99 Million - $2.76 Million	47,518 Added 1.59%	3,030,741 $140 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $1.19 Million - $1.4 Million	22,811 Added 0.77%	2,983,223 $164 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $526,779 - $684,825	-11,910 Reduced 0.4%	2,960,412 $153 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $98.7 Million - $138 Million	2,972,322 New	2,972,322 $129 Million

Others Institutions Holding AGIO

# of Institutions

207

Shares Held

60M

Call Options Held

365K

Put Options Held

457K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.31B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Agios Pharmaceuticals, Inc. Transaction History